Skip to main content
Top
Published in: Infection 5/2016

01-10-2016 | Original Paper

Antibiotic stewardship in a tertiary care hospital of a developing country: establishment of a system and its application in a unit—GASP Initiative

Authors: N. Shafiq, M. Praveen Kumar, V. Gautam, H. Negi, R. Roat, S. Malhotra, P. Ray, R. Agarwal, A. Bhalla, N. Sharma, R. Singh, G. D. Sharma, L. Bahadur, N. Yadanapudi, R. Gupta, G. Singh

Published in: Infection | Issue 5/2016

Login to get access

Abstract

Purpose

Despite the proven benefits of antimicrobial stewardship, models for executing the same in the developing countries are sparse. The present study highlights the approaches undertaken by our group in initiating one such program in a public sector tertiary level health care setting of a developing country.

Methods

The study focussed on development of a system after evaluation of existing issues and case study of implementation of the program in a unit within the hospital. The system building exercise included (1) development of generic data capture form for prospective audit and feedback; (2) development of an electronic system for data capture; (3) identification of key intervention points for strategy decision for stewardship in a particular unit; (4) application of the stewardship method and (5) evaluation of outcomes.

Results

A digital system for prospective audit was constructed after a background study. In the study unit, there was a significant decline in double anaerobic coverage. There was a significant decline in the average number of antimicrobials used per patients and a decrease in Defined Daily Dose of designated antimicrobials was noted. Additionally, there was an increase in the use of optimized doses.

Conclusion

A system for undertaking antimicrobial stewardship with a mechanism for prospective audit was put in place. The system may be adopted by other public sector hospitals of the developing country.
Literature
1.
go back to reference Golia S, Sangeetha KT, Vasudha CL. Microbial profile of early and late onset ventilator associated pneumonia in the intensive care unit of a tertiary care hospital in Bangalore, India. J Clin Diagn Res. 2013;7:2462–6.PubMedPubMedCentral Golia S, Sangeetha KT, Vasudha CL. Microbial profile of early and late onset ventilator associated pneumonia in the intensive care unit of a tertiary care hospital in Bangalore, India. J Clin Diagn Res. 2013;7:2462–6.PubMedPubMedCentral
2.
go back to reference Kapoor K, Jain S, Jajoo M, Dublish S, Dabas V, Manchanda V. Risk factors and predictors of mortality in critically ill children with extensively-drug resistant Acinetobacter baumannii infection in a pediatric intensive care unit. Iran J Pediatr. 2014;24:569–74.PubMedPubMedCentral Kapoor K, Jain S, Jajoo M, Dublish S, Dabas V, Manchanda V. Risk factors and predictors of mortality in critically ill children with extensively-drug resistant Acinetobacter baumannii infection in a pediatric intensive care unit. Iran J Pediatr. 2014;24:569–74.PubMedPubMedCentral
3.
go back to reference Viswanathan R, Singh AK, Basu S, Chatterjee S, Roy S, Isaacs D. Multi-drug-resistant, non-fermenting, gram-negative bacilli in neonatal sepsis in Kolkata, India: a 4-year study. Paediatr Int Child Health. 2014;34:56–9.CrossRefPubMed Viswanathan R, Singh AK, Basu S, Chatterjee S, Roy S, Isaacs D. Multi-drug-resistant, non-fermenting, gram-negative bacilli in neonatal sepsis in Kolkata, India: a 4-year study. Paediatr Int Child Health. 2014;34:56–9.CrossRefPubMed
4.
go back to reference Mukhopadhyay C, Chawla K, Krishna S, Nagalakshmi N, Rao SP, Bairy I. Emergence of Burkholderia pseudomallei and pandrug-resistant non-fermenters from southern Karnataka, India. Trans R Soc Trop Med Hyg. 2008;102:S12–7.CrossRefPubMed Mukhopadhyay C, Chawla K, Krishna S, Nagalakshmi N, Rao SP, Bairy I. Emergence of Burkholderia pseudomallei and pandrug-resistant non-fermenters from southern Karnataka, India. Trans R Soc Trop Med Hyg. 2008;102:S12–7.CrossRefPubMed
5.
go back to reference Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ. 2008;86:260–8.CrossRefPubMedPubMedCentral Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ. 2008;86:260–8.CrossRefPubMedPubMedCentral
6.
go back to reference Kothari A, Sagar V. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. J Infect Dev Ctries. 2008;2:354–8.CrossRefPubMed Kothari A, Sagar V. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. J Infect Dev Ctries. 2008;2:354–8.CrossRefPubMed
7.
go back to reference Thati V, Shivannavar CT, Gaddad SM. Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J Med Res. 2011;134:704–8.CrossRefPubMedPubMedCentral Thati V, Shivannavar CT, Gaddad SM. Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J Med Res. 2011;134:704–8.CrossRefPubMedPubMedCentral
8.
go back to reference Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. Characterization of a new metallo-beta-lactamase gene, bla (NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:5046–54. doi:10.1128/AAC.00774-09.CrossRefPubMedPubMedCentral Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. Characterization of a new metallo-beta-lactamase gene, bla (NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:5046–54. doi:10.​1128/​AAC.​00774-09.CrossRefPubMedPubMedCentral
9.
go back to reference Fomda BA, Khan A, Zahoor D. NDM-1 (New Delhi metallo beta lactamase-1) producing Gram-negative bacilli: emergence and clinical implications. Indian J Med Res. 2014;140:672–8.PubMedPubMedCentral Fomda BA, Khan A, Zahoor D. NDM-1 (New Delhi metallo beta lactamase-1) producing Gram-negative bacilli: emergence and clinical implications. Indian J Med Res. 2014;140:672–8.PubMedPubMedCentral
10.
go back to reference Shah RC, Shah P. Antimicrobial stewardship in institutions and office practices. Indian J Pediatr. 2008;75:815–20.CrossRefPubMed Shah RC, Shah P. Antimicrobial stewardship in institutions and office practices. Indian J Pediatr. 2008;75:815–20.CrossRefPubMed
11.
go back to reference Ghafur A, Malathi D, Muruganathan A, et al. The Chennai declaration: a roadmap to tackle the challenge of antimicrobial resistance. Indian J Cancer. 2013;50:71–3.CrossRefPubMed Ghafur A, Malathi D, Muruganathan A, et al. The Chennai declaration: a roadmap to tackle the challenge of antimicrobial resistance. Indian J Cancer. 2013;50:71–3.CrossRefPubMed
12.
go back to reference Ganguly NK, Arora NK, Chandy SJ, Global Antibiotic Resistance Partnership (GARP)––India Working Group, et al. Rationalizing antibiotic use to limit antibiotic resistance in India. Indian J Med Res. 2011;134:281–94.PubMed Ganguly NK, Arora NK, Chandy SJ, Global Antibiotic Resistance Partnership (GARP)––India Working Group, et al. Rationalizing antibiotic use to limit antibiotic resistance in India. Indian J Med Res. 2011;134:281–94.PubMed
13.
go back to reference Dellit TH, Owens RC, McGowan JE, et al. Infectious diseases society of america and the society for healthcare epidemiology of america guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.CrossRefPubMed Dellit TH, Owens RC, McGowan JE, et al. Infectious diseases society of america and the society for healthcare epidemiology of america guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.CrossRefPubMed
14.
go back to reference Elligsen M, Walker SA, Simor A, Daneman N. Prospective audit and feedback of antimicrobial stewardship in critical care: program implementation, experience, and challenges. Can J Hosp Pharm. 2012;65:31–6.PubMedPubMedCentral Elligsen M, Walker SA, Simor A, Daneman N. Prospective audit and feedback of antimicrobial stewardship in critical care: program implementation, experience, and challenges. Can J Hosp Pharm. 2012;65:31–6.PubMedPubMedCentral
15.
go back to reference Ibrahim OM, Polk RE. Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin North Am. 2014;28:195–214.CrossRefPubMed Ibrahim OM, Polk RE. Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin North Am. 2014;28:195–214.CrossRefPubMed
16.
go back to reference Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:e51–e77.CrossRefPubMed Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:e51–e77.CrossRefPubMed
18.
go back to reference Hermsen ED, VanSchooneveld TC, Sayles H, Rupp ME. Implementation of a clinical decision support system for antimicrobial stewardship. Infect Control Hosp Epidemiol. 2012;33:412–5.CrossRefPubMed Hermsen ED, VanSchooneveld TC, Sayles H, Rupp ME. Implementation of a clinical decision support system for antimicrobial stewardship. Infect Control Hosp Epidemiol. 2012;33:412–5.CrossRefPubMed
19.
go back to reference Calloway S, Akilo HA, Bierman K. Impact of a clinical decision support system on pharmacy clinical interventions, documentation efforts, and costs. Hosp Pharm. 2013;48:744–52.CrossRefPubMedPubMedCentral Calloway S, Akilo HA, Bierman K. Impact of a clinical decision support system on pharmacy clinical interventions, documentation efforts, and costs. Hosp Pharm. 2013;48:744–52.CrossRefPubMedPubMedCentral
20.
go back to reference Hutchinson JM, Patrick DM, Marra F, et al. Measurement of antibiotic consumption: a practical guide to the use of the anatomical therapeutic chemical classification and defined daily dose system methodology in Canada. Can J Infect Dis. 2004;15:29–35.CrossRefPubMedPubMedCentral Hutchinson JM, Patrick DM, Marra F, et al. Measurement of antibiotic consumption: a practical guide to the use of the anatomical therapeutic chemical classification and defined daily dose system methodology in Canada. Can J Infect Dis. 2004;15:29–35.CrossRefPubMedPubMedCentral
21.
22.
go back to reference Rattanaumpawan P, Morales KH, Binkley S, et al. Impact of antimicrobial stewardship programme changes on unnecessary double anaerobic coverage therapy. J Antimicrob Chemother. 2011;66:2655–8.CrossRefPubMedPubMedCentral Rattanaumpawan P, Morales KH, Binkley S, et al. Impact of antimicrobial stewardship programme changes on unnecessary double anaerobic coverage therapy. J Antimicrob Chemother. 2011;66:2655–8.CrossRefPubMedPubMedCentral
23.
go back to reference Song YJ, Kim M, Huh S, et al. Impact of an antimicrobial stewardship program on unnecessary double anaerobic coverage prescription. Infect Chemother. 2015;47:11–6. Song YJ, Kim M, Huh S, et al. Impact of an antimicrobial stewardship program on unnecessary double anaerobic coverage prescription. Infect Chemother. 2015;47:11–6.
24.
go back to reference Dellinger EP, Tellado JM, Soto NE, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann Surg. 2007;245:674–83.CrossRefPubMedPubMedCentral Dellinger EP, Tellado JM, Soto NE, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann Surg. 2007;245:674–83.CrossRefPubMedPubMedCentral
25.
go back to reference Beger HG, Rau B, Isenmann R, Schwarz M, Gansauge F, Poch B. Antibiotic prophylaxis in severe acute pancreatitis. Pancreatology. 2005;5:10–9.CrossRefPubMed Beger HG, Rau B, Isenmann R, Schwarz M, Gansauge F, Poch B. Antibiotic prophylaxis in severe acute pancreatitis. Pancreatology. 2005;5:10–9.CrossRefPubMed
26.
go back to reference Charani E, Castro-Sanchez E, Holmes A. The role of behavior change in antimicrobial stewardship. Infect Dis Clin North Am. 2014;28:169–75.CrossRefPubMed Charani E, Castro-Sanchez E, Holmes A. The role of behavior change in antimicrobial stewardship. Infect Dis Clin North Am. 2014;28:169–75.CrossRefPubMed
27.
go back to reference Tonkin-Crine S, Walker AS, Butler CC. Contribution of behavioural science to antibiotic stewardship. BMJ. 2015;350:h3413.CrossRefPubMed Tonkin-Crine S, Walker AS, Butler CC. Contribution of behavioural science to antibiotic stewardship. BMJ. 2015;350:h3413.CrossRefPubMed
28.
go back to reference John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis. 1997;24:471–85.CrossRefPubMed John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis. 1997;24:471–85.CrossRefPubMed
29.
go back to reference Singh I, Mittal R, Shafiq N, et al. A drug utilization study to provide background data for bringing amendments in the drug dispensing policy of a pediatric referral center. Pharmacoepidemiol Drug Saf. 2010;19:393–9.PubMed Singh I, Mittal R, Shafiq N, et al. A drug utilization study to provide background data for bringing amendments in the drug dispensing policy of a pediatric referral center. Pharmacoepidemiol Drug Saf. 2010;19:393–9.PubMed
30.
go back to reference Kaur S, Rajagopalan S, Kaur N, et al. Drug utilization study in medical emergency unit of a tertiary care hospital in North India. Emerg Med Int. 2014;2014:973578.CrossRefPubMedPubMedCentral Kaur S, Rajagopalan S, Kaur N, et al. Drug utilization study in medical emergency unit of a tertiary care hospital in North India. Emerg Med Int. 2014;2014:973578.CrossRefPubMedPubMedCentral
31.
go back to reference Kelkar D, Galwankar S. State of the globe: antimicrobial stewardship guides rationale use of antimicrobials to enable faster cure and prevent drug resistance. J Glob Infect Dis. 2013;5:43–4.CrossRefPubMedPubMedCentral Kelkar D, Galwankar S. State of the globe: antimicrobial stewardship guides rationale use of antimicrobials to enable faster cure and prevent drug resistance. J Glob Infect Dis. 2013;5:43–4.CrossRefPubMedPubMedCentral
Metadata
Title
Antibiotic stewardship in a tertiary care hospital of a developing country: establishment of a system and its application in a unit—GASP Initiative
Authors
N. Shafiq
M. Praveen Kumar
V. Gautam
H. Negi
R. Roat
S. Malhotra
P. Ray
R. Agarwal
A. Bhalla
N. Sharma
R. Singh
G. D. Sharma
L. Bahadur
N. Yadanapudi
R. Gupta
G. Singh
Publication date
01-10-2016
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2016
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0913-z

Other articles of this Issue 5/2016

Infection 5/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.